GL1X · GenesisL1 explorer

MolNFT v1 · #65630 · protein

Crystal structure of HCV NS5B polymerase in complex with a novel bicyclic dihydro-pyridinone inhibitor

3H2L: “Crystal structure of HCV NS5B polymerase in complex with a novel bicyclic dihydro-pyridinone inhibitor”. X-ray diffraction, 1 ligand (YAK), 14 pockets (best druggability 0.80). MolNFT v1 #65630 on GenesisL1: 3D structure, binding…

PDB
3H2L
Type
protein
Length
1,114 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NS5B polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
YAK
Pockets
14 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNS5B polymerase (EC 2.7.7.48)protein55749% helix, 15% strandP26663

Ligands and binding sites

  • YAK · N-{3-[(4aR,7aS)-1-(4-fluorobenzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-cyclopenta[b]pyridin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110620.800.8182YAK
210840.800.8191YAK
32950.680.8337empty
45890.670.7766empty
51100.480.8018empty

Interfaces

1 interface between chains.

  • A–B · 571 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 3H2L · Crystal structure of HCV NS5B polymerase in complex with a novel bicyclic dihydro-pyridi… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.